Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology

Standard of Care Treatment Strategies

At a Glance

Severe tricuspid valve stenosis is treated according to symptoms, valve anatomy, heart function, cause, and procedural risk. Diuretics can reduce fluid buildup, but some patients need balloon treatment, surgery, or valve-in-valve therapy.

When the tricuspid valve becomes severely narrowed, the goal of treatment shifts to addressing the obstruction. Because isolated tricuspid stenosis is rare, interventions are highly individualized based on symptoms, severity, valve anatomy, right-ventricular status, and procedural risk. Some patients may be monitored while the specialized valve team weighs the timing, while others may eventually need a procedure [1][2].

Medical Management: Relieving the Backup

Before or alongside any procedure, your doctor will use medications to manage systemic venous congestion (the backup of fluid in your body) [3].

  • Diuretics: These are “water pills” (such as furosemide) that help your kidneys remove excess salt and water [4]. Dosing must be carefully individualized to reduce swelling in the legs and abdomen without causing dehydration or kidney injury [5]. Never adjust your diuretic dose without a clinician-approved action plan. Your team will regularly monitor your renal function, potassium, sodium, blood pressure, and weight.
  • Limitations: It is important to understand that diuretics do not fix the valve itself [6]. They only treat the “downstream” effects of the narrowing. In severe cases, the obstruction is so tight that diuretics alone cannot resolve the congestion [5].

The Treatment Framework

The choice of procedure depends on the underlying cause of your stenosis (e.g., if a pacemaker lead is the cause, an electrophysiology assessment may be needed; if carcinoid, tumor management is required), your surgical risk, and whether other valves in your heart also need attention.

1. Percutaneous Balloon Valvuloplasty

This is a minimally invasive procedure where a thin tube with a balloon at the tip is threaded through a vein to the heart. The balloon is inflated inside the narrowed valve to stretch it open [1].

  • Who it’s for: Considered in highly selected cases for patients with rheumatic or congenital stenosis who have favorable valve anatomy [7]. It may also be used as a “bridge” to surgery for patients who are currently too ill for a major operation [5].
  • Pros/Cons: It avoids a large incision and has a shorter recovery. However, the evidence base for native tricuspid balloon intervention is much smaller than for mitral disease, and it carries risks of restenosis (narrowing again) and worsening tricuspid regurgitation [1][6].

2. Surgical Repair or Replacement

Surgery remains the conventional definitive treatment for severe tricuspid stenosis [1].

  • Repair (Commisurotomy): The surgeon manually separates the fused leaflets. When feasible, repair is generally associated with lower operative mortality and fewer complications, such as renal failure, compared to replacement [8]. However, outcomes depend heavily on your anatomy and whether you are having concomitant surgery.
  • Replacement: If the valve is too damaged to repair, it is replaced with either a bioprosthetic (biological tissue) or mechanical valve [9].
    • Mechanical valves are highly durable but require lifelong vitamin-K-antagonist anticoagulation (blood thinners) and regular monitoring.
    • Biological valves are often used in the tricuspid position [10]. While they may not require lifelong anticoagulation, you may still need it for an initial postoperative period, or long-term if you have atrial fibrillation. Bioprosthetic valves can also wear out over time.

3. Transcatheter Valve-in-Valve (TViV) Therapy

This is a newer, specialized option for some carefully selected patients who already have a failing biological (bioprosthetic) valve from a previous surgery [11][12].

  • The Procedure: A new transcatheter valve is placed directly inside the old, narrowed surgical valve without the need for a second open-heart surgery [13].
  • Benefits: It has a high procedural success rate and can significantly improve symptoms for patients who are at high risk for a “redo” operation [14][13].

Timing Your Intervention

The decision to move from “watching and waiting” to a procedure is individualized, but is often considered when you have severe stenosis and one of the following:

  • You have symptoms (like severe swelling or shortness of breath) that are not controlled by medicine [1].
  • You are already having surgery for valves on the left side of your heart (like the mitral or aortic valve) [15][16].
  • You have a pacemaker lead causing the obstruction that cannot be managed with medication [2][17].

Your specialized care team will use a combination of your symptoms, ultrasound measurements, and overall health to determine which path is safest and most effective for you.

Common questions in this guide

What medicines can help symptoms from tricuspid valve stenosis?
Diuretics, sometimes called water pills, help the kidneys remove extra salt and water, which can reduce swelling and fluid buildup. They do not open the narrowed valve, and the dose should be adjusted only with a clinician’s plan because dehydration and kidney or electrolyte problems can occur.
When might I need a procedure for severe tricuspid stenosis?
A procedure may be considered when severe symptoms such as swelling or shortness of breath continue despite medicine. Treatment may also be addressed during surgery for another heart valve or when a pacemaker lead is causing an obstruction that cannot be managed with medication.
Could balloon valvuloplasty treat my tricuspid valve stenosis?
Balloon valvuloplasty may be an option for carefully selected people with rheumatic or congenital tricuspid stenosis and favorable valve anatomy. It can avoid a large incision, but the valve may narrow again and the procedure can worsen leakage through the valve.
Is repairing the tricuspid valve better than replacing it?
Repair may be preferred when the valve anatomy allows it because it is generally associated with lower operative risk and fewer complications than replacement. If the valve is too damaged to repair, it may be replaced with a mechanical or biological valve, each of which has different long-term considerations.
What are the differences between mechanical and biological tricuspid valves?
Mechanical valves are durable but require lifelong treatment with a vitamin-K-antagonist blood thinner and regular monitoring. Biological valves may not require lifelong blood thinning unless another condition such as atrial fibrillation makes it necessary, but they can wear out over time.
What is transcatheter valve-in-valve treatment?
Valve-in-valve treatment places a new transcatheter valve inside a failing biological valve from an earlier surgery. It may improve symptoms and avoid a second open-heart operation in carefully selected patients, especially those at high risk for repeat surgery.

Get notified when new evidence is published on tricuspid valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Percutaneous Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis.

    Rana G, Malhotra R, Sharma A, Kakouros N

    Texas Heart Institute journal 2017; (44(1)):43-49 doi:10.14503/THIJ-15-5408.

    PMID: 28265212
  2. 2

    Severe Tricuspid Stenosis Secondary to Permanent Pacemaker Lead.

    Khan A, Mustafa A, Ling J, Lafferty J

    Journal of medical cases 2022; (13(8)):365-368 doi:10.14740/jmc3900.

    PMID: 36128066
  3. 3

    Bioprosthetic tricuspid valve stenosis: a case series.

    Hirata K, Tengan T, Wake M, et al.

    European heart journal. Case reports 2019; (3(3)) doi:10.1093/ehjcr/ytz110.

    PMID: 31367735
  4. 4

    A Narrative Review on the Efficacy and Safety of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction.

    Pius R, Odukudu GO, Olorundare I, et al.

    Cureus 2023; (15(9)):e45794 doi:10.7759/cureus.45794.

    PMID: 37872937
  5. 5

    Pulmonary and tricuspid valvuloplasty in carcinoid heart disease.

    Karimi A, Pourafshar N, Fudge JC

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2018; (91(7)):E68-E71 doi:10.1002/ccd.26615.

    PMID: 28029208
  6. 6

    Tricuspid valve diseases: Interventions on the forgotten heart valve.

    Yoganathan A, Khan SNM, Khan H, et al.

    Journal of cardiac surgery 2021; (36(1)):219-228 doi:10.1111/jocs.15159.

    PMID: 33135830
  7. 7

    Balloon valvuloplasty for annular- and leaflet-level tricuspid stenosis: Report of cases and literature review.

    Ephrem G, Gorocica-Romero R, Day J, et al.

    The Journal of invasive cardiology 2024; (36(1)) doi:10.25270/jic/23.00205.

    PMID: 38224293
  8. 8

    Isolated surgical tricuspid repair versus replacement: meta-analysis of 15 069 patients.

    Wang TKM, Griffin BP, Miyasaka R, et al.

    Open heart 2020; (7(1)):e001227 doi:10.1136/openhrt-2019-001227.

    PMID: 32206317
  9. 9

    Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies.

    Scotti A, Sturla M, Granada JF, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2022; (18(10)):840-851 doi:10.4244/EIJ-D-22-00442.

    PMID: 36197445
  10. 10

    Should a Mechanical or Biological Prosthesis Be Used for a Tricuspid Valve Replacement? A Meta-Analysis.

    Liu P, Qiao WH, Sun FQ, et al.

    Journal of cardiac surgery 2016; (31(5)):294-302 doi:10.1111/jocs.12730.

    PMID: 26956806
  11. 11

    Percutaneous Tricuspid Valve-in-Valve Implantation With Melon Seeding During Deployment.

    Sellers AM, Ravat S, Bennetts J, et al.

    JACC. Case reports 2026; (31(39)):109732 doi:10.1016/j.jaccas.2026.109732.

    PMID: 42603160
  12. 12

    Tricuspid valve-in-valve implantation for failing bioprosthetic valves: an evolving standard of care.

    Panaich SS, Eleid MF

    Annals of translational medicine 2016; (4(20)):410 doi:10.21037/atm.2016.10.44.

    PMID: 27867962
  13. 13

    Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study.

    McElhinney DB, Cabalka AK, Aboulhosn JA, et al.

    Circulation 2016; (133(16)):1582-93 doi:10.1161/CIRCULATIONAHA.115.019353.

    PMID: 26994123
  14. 14

    Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.

    Ruparelia N, Mangieri A, Ancona M, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2016; (88(6)):994-1001 doi:10.1002/ccd.26584.

    PMID: 27184831
  15. 15

    Predominant Rheumatic Tricuspid Stenosis.

    Alizadeh L, Vainrib AF, Ro R, et al.

    JACC. Case reports 2025; (30(33)):104808 doi:10.1016/j.jaccas.2025.104808.

    PMID: 41136055
  16. 16

    An overview of surgical treatment modalities and emerging transcatheter interventions in the management of tricuspid valve regurgitation.

    Van Praet KM, Stamm C, Starck CT, et al.

    Expert review of cardiovascular therapy 2018; (16(2)):75-89 doi:10.1080/14779072.2018.1421068.

    PMID: 29283684
  17. 17

    Tricuspid stenosis: An emerging disease in cardiac implantable electronic devices era. Case report and literature review.

    Husain A, Raja FT, Fatallah A, et al.

    Journal of cardiology cases 2017; (15(6)):190-193 doi:10.1016/j.jccase.2017.02.003.

    PMID: 30279777

This page explains treatment options for tricuspid valve stenosis for informational purposes only and does not replace medical advice. Discuss medication changes, procedure timing, valve choices, and risks with your cardiology or specialized valve team.